4//SEC Filing
Bright Rex 4
Accession 0001209191-20-015191
CIK 0001606645other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:31 PM ET
Size
5.5 KB
Accession
0001209191-20-015191
Insider Transaction Report
Form 4
Bright Rex
Director
Transactions
- Award
Options
2020-02-27+38,156→ 38,156 totalExercise: $3.53Exp: 2030-02-27→ Ordinary Shares (38,156 underlying)
Footnotes (2)
- [F1]Each option represents a contingent right to purchase one ordinary share of the issuer.
- [F2]The ordinary shares underlying this option award vest over a 12 month period, in equal, quarterly installments, ending February 27, 2021.
Documents
Issuer
Foamix Pharmaceuticals Ltd.
CIK 0001606645
Entity typeother
Related Parties
1- filerCIK 0001327501
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:31 PM ET
- Size
- 5.5 KB